Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12122773
Crystalline hydrate of a JAK inhibitor compound
granted -
US 12122815
GIP receptor agonist peptide compounds and uses thereof
granted -
US 12123002
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
granted -
US 12123012
Methods and compositions for nucleic acid and protein payload delivery
granted -
US 12122998
Materials and methods for treatment of usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)
granted -
US 12122843
High affinity monoclonal antibodies targeting glypican-1 and methods of use
granted -
US 12122846
Chimeric antigen receptor for tumor targeting
granted -
US 12123001
Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors
granted -
US 12123035
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12121540
CBL inhibitors and compositions for use in adoptive cell therapy
granted -
US 12121542
BCMA chimeric antigen receptor based on single domain antibody and use thereof
granted -
US 12121532
Modified antisense oligomers for exon inclusion in spinal muscular atrophy
granted -
US 12121541
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12121503
Antiviral treatments
granted -
US 12121608
Biodegradable implant for sustained trans-nasal delivery of therapeutic agents to the brain
granted -
US 12121288
Combination tumor treatment
granted -
US 12121526
Targeting NCCA-ATP channel for organ protection following ischemic episode
granted -
US 12121567
Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulfatase using a recombinant adeno-associated virus (AAV) vector encoding iduronate-2-sulfatase
granted -
US 12121523
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
granted -
US 12121522
Methods of treating cancer with an mTOR inhibitor
granted -
US 12121571
Recombinant L-asparaginase
granted -
US 12121569
Methods and compositions for CNS delivery of iduronate-2-sulfatase
granted -
US 12121580
Antibacterial photodynamic therapy using copper-cysteamine nanoparticles
granted -
WO 2024216080
RÉGIMES IMMUNOSUPPRESSEURS ET PROCÉDÉS ASSOCIÉS
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.